CANF
Can-Fite Biopharma Ltd ADR
3월 13일 4:00 PM ET (한국 3/14 05:00)
$3.60
-0.12 ▼ -3.23%
🌙 3월 13일 7:50 PM ET (한국 3/14 08:50)
$3.65
+0.05 ▲ +1.39%
| Index | - | P/E | - | EPS (ttm) | - | Insider Own | - | Shs Outstand | 0.00B | Perf Week | -20.88% |
| Market Cap | 0.00B | Forward P/E | - | EPS next Y | -38.46% | Insider Trans | - | Shs Float | - | Perf Month | -18.18% |
| Enterprise Value | -0.00B | PEG | - | EPS next Q | -0.14 | Inst Own | 2.28% | Short Float | - | Perf Quarter | -41.94% |
| Income | - | P/S | - | EPS this Y | 95.09% | Inst Trans | -4.78% | Short Ratio | 0.1 | Perf Half Y | -72.73% |
| Sales | - | P/B | 0 | EPS next 5Y | - | ROA | - | Short Interest | 0.09M | Perf YTD | -10% |
| Book/sh | 949.15 | P/C | 0.73 | EPS past 3/5Y | 49.06% 52.31% | ROE | - | 52W High | -92.27% ($46.60) | Perf Year | -88.48% |
| Cash/sh | 4.93 | P/FCF | - | Sales past 3/5Y | -7.43% -19.78% | ROIC | - | 52W Low | 7.27% ($3.36) | Perf 3Y | -92.86% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 50.34% | Gross Margin | - | Volatility(W/M) | 7.98% 12.41% | Perf 5Y | -99.09% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.63 | Perf 10Y | -99.95% |
| Dividend Ex-Date | - | Quick Ratio | 3.6 | EPS Q/Q | 66.85% | Profit Margin | - | RSI (14) | 38.52 | Recom | 3 |
| Dividend Gr. 3/5Y | - | Current Ratio | 3.6 | Sales Q/Q | -20.25% | SMA20 | -20.21% ($4.51) | Beta | 0.98 | Target Price | $79.92 |
| Payout | - | Debt/Eq | 0.02 | Earnings | - | SMA50 | -17.07% ($4.34) | Rel Volume | 0.06 | Prev Close | $3.72 |
| Employees | 5 | LT Debt/Eq | 0.01 | EPS/Sales Surpr. | - | SMA200 | -67.06% ($10.93) | Avg Volume(3M) | 0.89M | Price | $3.6 |
| IPO | 2012/11/1 | Option/Short | No/Yes | Trades | 422 | Volume | 53,723 | Change | -3.23% |
뉴스 로딩 중...